Chuo-ku, Japan

Kenji Sudo




Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 21(Granted Patents)


Location History:

  • Fukushima, JP (1997)
  • Tsukuba, JP (2005)
  • Chuo-ku, JP (2008)

Company Filing History:


Years Active: 1997-2008

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Kenji Sudo: A Leader in Pharmaceutical Patents

Introduction

Kenji Sudo is a notable inventor based in Chuo-ku, Japan, recognized for his significant contributions to the pharmaceutical industry. With a total of three patents to his name, Sudo’s work focuses primarily on developing novel compounds for the therapeutic treatment of various diseases caused by herpesvirus family infections.

Latest Patents

Sudo’s latest patents include groundbreaking pharmaceutical drugs that showcase his commitment to advancing medical science. One of his key inventions is an "Amide derivative," which provides a novel compound effective for prophylaxis and therapeutic treatment against a range of herpesvirus infections. These include varicella (chicken pox) through varicella zoster virus, as well as herpes labialis and genital herpes resulting from HSV-1 and HSV-2 infections. This compound, specifically N-{2-[(4-substituted phenyl)amino]-2-oxoethyl}tetrahydro-2H-thiopyran-4-carboxamide derivative, demonstrates notable anti-virus activity, allowing for effective oral administration at low doses.

In addition, Sudo also developed a "Tetrahydro-2H-thiopyran-4-carboxamide derivative," which shares similar applications in treating diseases linked to the Herpesviridae family. This derivative, characterized by its N-{2-[(4-substituted phenyl)amino]-2-oxoethyl} structure, also provides impressive antiviral properties, contributing to enhanced treatment options for conditions caused by these viruses.

Career Highlights

Throughout his career, Kenji Sudo has worked with reputable institutions, further expanding his expertise and impact in the pharmaceutical sector. He has notably contributed to Rational Drug Design Laboratories and Yamanouchi Pharmaceutical Company Ltd., where he applied his innovative thinking to solve pressing health challenges.

Collaborations

Sudo’s work has been enriched by collaborations with talented colleagues such as Toru Kontani and Junji Miyata. These collaborations have enabled a rich exchange of ideas and a synergistic approach toward the development of effective therapeutic solutions.

Conclusion

Kenji Sudo’s innovations in pharmaceutical compounds underscore his dedication to enhancing healthcare through scientific discovery. With his three patents focusing on effective treatments for herpesvirus infections, Sudo stands out as a prominent inventor committed to improving patient outcomes in the face of viral diseases. His journey reflects the impact of innovation in the medical field, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…